June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Collagen type 1-containing PHEMA hydrogels support enhanced viability and biointegration of human keratocytes.
Author Affiliations & Notes
  • Elizabeth B Moloney
    REMEDI, National University of Ireland Galway, Galway, Galway, Ireland
    College of Science and Engineering, National University of Ireland, Galway, Ireland
  • Laura Sánchez-Abella
    CIDETEC, Basque Research and Technology Alliance, Donostia-San Sebastián, Spain
  • Beatriz Palla Rubio
    CIDETEC, Basque Research and Technology Alliance, Donostia-San Sebastián, Spain
  • Maria González
    AJL Ophthalmic, Alava, Spain
  • Damien Dupin
    CIDETEC, Basque Research and Technology Alliance, Donostia-San Sebastián, Spain
  • Eva Larra
    AJL Ophthalmic, Alava, Spain
  • Iraida Loinaz
    CIDETEC, Basque Research and Technology Alliance, Donostia-San Sebastián, Spain
  • Abhay Pandit
    CURAM, National University of Ireland Galway, Galway, Galway, Ireland
    College of Science and Engineering, National University of Ireland, Galway, Ireland
  • Thomas Ritter
    REMEDI, National University of Ireland Galway, Galway, Galway, Ireland
    College of Medicine Nursing and Health Science, National University of Ireland, Galway, Ireland
  • Footnotes
    Commercial Relationships   Elizabeth Moloney None; Laura Sánchez-Abella None; Beatriz Palla Rubio None; Maria González None; Damien Dupin None; Eva Larra None; Iraida Loinaz None; Abhay Pandit None; Thomas Ritter None
  • Footnotes
    Support  EU H2020 grant 814439 (TBMED)
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 93 – A0191. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Elizabeth B Moloney, Laura Sánchez-Abella, Beatriz Palla Rubio, Maria González, Damien Dupin, Eva Larra, Iraida Loinaz, Abhay Pandit, Thomas Ritter; Collagen type 1-containing PHEMA hydrogels support enhanced viability and biointegration of human keratocytes.. Invest. Ophthalmol. Vis. Sci. 2022;63(7):93 – A0191.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate if the production of PHEMA (poly(2-hydroxyethyl methacrylate)), a biomaterial previously used in artificial corneas, with biomacromolecules enhances viability and integration of human corneal keratocytes (HCK).

Methods : Several varieties of PHEMA-based hydrogels were prepared with 0.05% collagen (COL-I), 0.1% COL-I, 0.2% COL-I, or 0.1% COL-I in combination with 0.025% hyaluronic acid (HA). Samples were individually sterilized by beta-irradiation prior to use in vitro. HCK were seeded at a density of 2x104 cells/cm2 onto the top surface of hydrogel discs of different compositions. Viability at 5 days post-seeding was measured by quantifying ATP released from metabolically viable cells. Infiltration of cells into the porous biomaterial was quantified by counting the number of DAPI-stained nuclei in horizontal cryosections of HCK-seeded hydrogel buttons. To determine whether corneal cells exposed to the various hydrogels alter their secreted MMP profile, conditioned media was collected 6 days post-seeding for semi-quantification of MMPs using an antibody array dot blot approach.

Results : Only PHEMA-based hydrogels prepared in the presence of 0.1% COL-I alone supported statistically significant enhanced viability of HCK across three independent assays (p<0.05) when compared to viability on unmodified PHEMA hydrogels (n=6 samples per hydrogel, per assay; One-way ANOVA, with Dunnett’s multiple comparison test). Preliminary data suggested that collagen-only modified PHEMA hydrogels (0.1% or 0.2% COL-I) encouraged deeper infiltration of cells into the biomaterial. MMP levels secreted from HCK grown on modified hydrogels were expressed as fold-change compared to levels observed from cells grown on unmodified samples (p<0.01, one-way ANOVA, with Tukey’s multiple comparison test). MMP 1 and MMP 3 levels were significantly increased in all modified hydrogels samples, whereas MMP8, MMP10, and MMP13 remained constant across all samples. COL-I-only hydrogels elicited a significant decrease in MMP2 levels, whereas MMP9 levels were only significantly reduced when HCKs were cultured on hydrogels containing both HA and COL-I.

Conclusions : By supporting enhanced survival of HCK in vitro, PHEMA hydrogels containing 0.1% COL-I may allow for improved biointegration of hydrogel-based keratoprosthesis in diseased eyes.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×